Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR

NCT06057350 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 304

Last updated 2024-02-16

No results posted yet for this study

Summary

Randomized head-to-head comparison trial among patients who have undergone incomplete endoscopic resection of early colon cancer to evaluate the benefits, harms and burdens, as well as the ecological footprint and cost-effectiveness of endoscopic full thickness resection (eFTR), a minimally invasive endoscopic treatment with a colonoscope, as compared to standard-of-care surgery.

Co-primary endpoints are

* Rate of severe adverse events classified as grade III to V according to the Clavien Dindo classification within 30-days after study treatment
* CRC recurrence or sign of lymph nodes or distant metastases at 3 years after randomization comparing the two treatment groups (eFTR versus surgery).

Conditions

Interventions

PROCEDURE

Tumor removal

Removal of incompletely removed early-stage colon cancer

Sponsors & Collaborators

  • Hôpital Edouard Herriot

    collaborator OTHER
  • Maria Sklodowska-Curie National Research Institute of Oncology

    collaborator OTHER
  • Nuovo Regina Margherita Hospital

    collaborator OTHER
  • Karolinska Institutet

    collaborator OTHER
  • Humanitas Clinical and Research Center

    collaborator OTHER
  • Medical University of Gdansk

    collaborator OTHER
  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER
  • University Hospital, Akershus

    collaborator OTHER
  • Vestre Viken Hospital Trust

    collaborator OTHER
  • University Hospital of North Norway

    collaborator OTHER
  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Oslo University Hospital

    collaborator OTHER
  • Norwegian Department of Health and Social Affairs

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-27
Primary Completion
2031-09-30
Completion
2033-09-30

Countries

  • Norway
  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06057350 on ClinicalTrials.gov